Green Thumb Industries GTBIF Stock Analysis And what the future holds for cannabis stocks

UniSA seeks public support for vital research on deadly brain cancers

The University of South Australia is seeking public support for vital brain cancer research that could potentially save hundreds of lives.

October 31, 2023

Leveragen and Moderna enter partnership to advance therapeutics

Leveragen will use the platform to create several binding modules against therapeutic targets chosen by Moderna. Credit: MIND AND I / Shutterstock. Leveragen and Moderna

July 31, 2024

Skyline wins orphan drug designation for retinitis pigmentosa gene therapy – Pharmaceutical Technology

Retinitis pigmentosa can eventually lead to complete blindness. Credit: GBJSTOCK via Shutterstock. Gene therapy company Skyline Therapeutics has secured an orphan drug designation from the

September 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.